aTyr Pharma (LIFE)
(Delayed Data from NSDQ)
$1.60 USD
-0.02 (-1.23%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $1.61 +0.01 (0.63%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for aTyr Pharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -50.40 | -45.34 | -33.78 | -16.23 | -23.76 |
Depreciation/Amortization & Depletion | -0.43 | 2.23 | 1.67 | 1.72 | 1.79 |
Net Change from Assets/Liabilities | 15.01 | -0.83 | -2.59 | -2.26 | 0.21 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.59 | 2.06 | 1.62 | 1.47 | 1.76 |
Net Cash From Operating Activities | -33.22 | -41.89 | -33.08 | -15.30 | -20.01 |
Property & Equipment | -4.20 | -1.46 | -0.14 | -0.18 | -0.03 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -15.93 | 48.71 | -91.42 | 7.08 | 4.95 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -20.13 | 47.25 | -91.57 | 6.90 | 4.93 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 66.62 | 5.52 | 110.03 | 25.23 | 9.34 |
Issuance (Repayment) of Debt | -0.39 | -0.07 | 0.00 | -9.08 | -8.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 66.23 | 5.45 | 110.03 | 16.14 | 1.34 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 12.88 | 10.81 | -14.62 | 7.74 | -13.75 |
Cash at Beginning of Period | 13.15 | 2.34 | 16.95 | 9.21 | 22.96 |
Cash at End of Period | 26.03 | 13.15 | 2.34 | 16.95 | 9.21 |
Diluted Net EPS | -0.94 | -1.60 | -1.77 | -1.77 | -7.03 |
Fiscal Year End for aTyr Pharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -50.40 | -35.64 | -24.29 | -11.95 |
Depreciation/Amortization & Depletion | NA | -0.43 | 0.06 | 0.04 | 0.34 |
Net Change from Assets/Liabilities | NA | 15.01 | 11.49 | 10.39 | 10.41 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 2.59 | 1.93 | 1.26 | 0.62 |
Net Cash From Operating Activities | NA | -33.22 | -22.16 | -12.60 | -0.59 |
Property & Equipment | NA | -4.20 | -4.18 | -3.63 | -1.25 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -15.93 | -33.76 | -38.70 | -36.93 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -20.13 | -37.95 | -42.33 | -38.17 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 66.62 | 60.48 | 57.69 | 49.56 |
Issuance (Repayment) of Debt | NA | -0.39 | -0.28 | -0.17 | -0.07 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 66.23 | 60.20 | 57.51 | 49.50 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 12.88 | 0.09 | 2.59 | 10.73 |
Cash at Beginning of Period | NA | 13.15 | 13.15 | 13.15 | 13.15 |
Cash at End of Period | NA | 26.03 | 13.24 | 15.73 | 23.88 |
Diluted Net EPS | NA | -0.23 | -0.20 | -0.22 | -0.29 |